Royal Bank of Canada’s Portage Biotech PRTG Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Sell |
75
-4
| -5% | – | ﹤0.01% | 6815 |
|
2025
Q1 | $1K | Sell |
79
-1,496
| -95% | -$18.9K | ﹤0.01% | 6315 |
|
2024
Q4 | $8K | Buy |
1,575
+1,500
| +2,000% | +$7.62K | ﹤0.01% | 5920 |
|
2024
Q3 | $0 | Sell |
75
-1,726
| -96% | – | ﹤0.01% | 6785 |
|
2024
Q2 | $0 | Buy |
1,801
+152
| +9% | – | ﹤0.01% | 6933 |
|
2024
Q1 | $1K | Buy |
1,649
+22
| +1% | +$13 | ﹤0.01% | 6392 |
|
2023
Q4 | $3K | Sell |
1,627
-1,407
| -46% | -$2.59K | ﹤0.01% | 6200 |
|
2023
Q3 | $6K | Sell |
3,034
-300
| -9% | -$593 | ﹤0.01% | 6081 |
|
2023
Q2 | $12K | Buy |
3,334
+1,705
| +105% | +$6.14K | ﹤0.01% | 5961 |
|
2023
Q1 | $5K | Sell |
1,629
-281
| -15% | -$862 | ﹤0.01% | 6189 |
|
2022
Q4 | $10K | Buy |
1,910
+288
| +18% | +$1.51K | ﹤0.01% | 6076 |
|
2022
Q3 | $11K | Buy |
1,622
+112
| +7% | +$760 | ﹤0.01% | 5899 |
|
2022
Q2 | $11K | Sell |
1,510
-306
| -17% | -$2.23K | ﹤0.01% | 5885 |
|
2022
Q1 | $12K | Sell |
1,816
-854
| -32% | -$5.64K | ﹤0.01% | 6394 |
|
2021
Q4 | $29K | Buy |
2,670
+2,064
| +341% | +$22.4K | ﹤0.01% | 6103 |
|
2021
Q3 | $13K | Buy |
606
+596
| +5,960% | +$12.8K | ﹤0.01% | 6349 |
|
2021
Q2 | $0 | Sell |
10
-700
| -99% | – | ﹤0.01% | 7038 |
|
2021
Q1 | $20K | Buy |
+710
| New | +$20K | ﹤0.01% | 5929 |
|